INNA-051 Influenza Challenge Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is a Phase 2, randomized, double-blind, placebo-controlled study of INNA-051 in healthy adults, administered prior to administration of an influenza challenge virus. This study will evaluate 2 active dose levels of INNA-051 and placebo.
Epistemonikos ID: 59bec99d657dc021059f852fea4301bca28044d4
First added on: May 10, 2024